Poly Medicure

₹1,598As of Sun 8 Nov 2026, 12:00 UTC
NSE:POLYMEDHealthcare
Country India
PE (Fwd) 40.76
TSR 10Y CAGR 23.52%
Div yield 0.22%
ROE —
Medical Instruments & Supplies
Beta (5Y) 0.11
PE TTM 50.34
TSR TTM (19.90%)
Mkt cap ₹163.7B
ROIC —
SE Grade™
Value
Quality
Moat
1Y Price
Reference
₹1,794
12.22%
(83.93%)
Price above Reference Value
FY23
FY24
FY25
FY26
Earnings per share₹
18.67
26.90
34.11
31.75
22.27%
44.08%
26.80%
(6.92%)
Revenue₹B
11.15
13.76
16.70
18.75
20.82%
23.36%
21.37%
12.30%
TTM
FYE 31 Mar INR
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
FY2027E
Trend
5Y
10Y
Peers
18.75
Revenue₹B
—
—
—
—
—
9.231
11.15
13.76
16.70
18.75
20.96
19.39%
19.39%
17
12.30
Revenue growth%
—
—
—
—
—
—
20.82
23.36
21.37
12.30
11.75
21.10
—
83
67.85
Gross margin%
—
—
—
—
—
62.02
63.32
64.62
66.49
67.85
67.89
64.62
64.62
72
17.55
Operating margin%
—
—
—
—
—
17.29
19.08
21.54
22.26
17.55
17.60
19.08
19.08
70
17.18
Net margin%
—
—
—
—
—
15.87
16.08
18.77
20.27
17.18
17.18
17.18
17.18
79
50.34
P/E ratio (avg)x
—
—
—
—
—
63.56
47.12
50.25
67.92
57.92
45.03
57.92
57.92
36
49.28
EV/EBITx
—
—
—
—
—
58.34
39.70
43.80
61.88
56.71
43.96
56.71
56.71
24
—
FCF yield (avg)%
—
—
—
—
—
—
—
—
—
—
—
—
—
20
—
FCF margin%
—
—
—
—
—
—
—
—
—
—
—
—
—
17
—
FCF / Net incomex
—
—
—
—
—
—
—
—
—
—
—
—
—
12
—
ROIC%
—
—
—
—
—
—
—
—
—
—
—
—
—
63
—
Return on equity%
—
—
—
—
—
—
—
—
—
—
—
—
—
72
—
Return on assets%
—
—
—
—
—
—
—
—
—
—
—
—
—
66
31.75
EPS₹
—
—
—
—
—
15.27
18.67
26.90
34.11
31.75
35.50
20.09%
20.09%
—
(6.92)
EPS growth%
—
—
—
—
—
—
22.30
44.05
26.83
(6.92)
11.80
24.57
—
—
—
Bookvalue per sh₹
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
FCF per share₹
—
—
—
—
—
—
—
—
—
—
—
—
—
—
3.50
Dividend per sh₹
—
—
—
—
—
2.50
3.00
3.00
3.50
3.50
3.64
8.78%
8.78%
—
0.22
Div yield (avg)%
—
—
—
—
—
0.26
0.34
0.22
0.15
0.19
0.23
0.22
0.22
5
11.02
Payout ratio%
—
—
—
—
—
16.37
16.07
11.15
10.26
11.02
10.25
11.15
11.15
10
101.4
Shares (diluted)M
◇—
—
—
—
—
95.96
96.02
96.02
99.24
101.4
◌101.4
1.40%
1.40%
—
(2.22)
Buyback yield%
—
—
—
—
—
—
(0.06)
—
(3.36)
(2.22)
◌—
(1.14)
—
—
—
D/E ratiox
—
—
—
—
—
—
—
—
—
—
—
—
—
70
162.2
Enterprise value₹B
—
—
—
—
—
93.12
84.47
129.8
229.9
186.6
162.2
18.98%
18.98%
57
—
LT debt₹M
—
—
—
—
—
—
—
—
—
—
—
—
—
27
Peers (US$1.743B)
Cap (US$)
PE
13.46B
161.7x
179.2M
152.5x
Capital
TTM
5Y
10Y
Leveragex
—
—
—
EBIT/Intx
17.80
30.98
30.98
Own earn%
—
—
—
Sh yield%
(2.00)
(0.90)
(0.90)
Owners
Insiders/Inst%
36.98
21.53
Short interest%
—
SBC / revenue%
0.41
Record
10Y
Profitable years
5/5
Revenue growth years
4/4
EPS growth years
3/4
Dividend streakyrs
1
Op margin range%
17–22
$1 testx
—
Incr. ROIC%
—

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally.

Growth vs revenue
Latest
Trend
4Y CAGR
Rel growth
Revenue
₹18.75B
19.39%
1.00×
Cost of revenue
₹6.030B
14.52%
0.85×
Operating expenses
₹9.432B
22.95%
1.12×
Revenue by region
No breakdown available
Reinvestment returns
n/m
Trend
Reinvestment rate
n/m
-
Return on capital
n/m
-
Spread over hurdle
n/m
-